alexa Relapsing-remitting Multiple Sclerosis Open Access Articles|omicsgroup|Journal Of Multiple Sclerosis

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Relapsing-remitting Multiple Sclerosis Open Access Articles

Multiple sclerosis (MS) is defined as a probable autoimmune disease that severely affects the central nervous system (CNS), resulting in several pathologies that may be a result of different disease-causing mechanisms. Relapsing-Remitting Multiple Sclerosis is a common form of multiple sclerosis characterised by clear exacerbations due to inflammation. The disease is characterised by various symptoms such as bowel dysfunction, numbness, spasticity, balance issues, vertigo and pain. The common oral drugs being used for the treatment involves Gilenya, Aubagio, and Tecfidera. Open access to the scientific literature means the removal of barriers (including price barriers) from accessing scholarly work. There are two parallel roads towards open access: Open Access articles and self-archiving. Open Access articles are immediately, freely available on their Web site, a model mostly funded by charges paid by the author (usually through a research grant). The alternative for a researcher is “self-archiving” (i.e., to publish in a traditional journal, where only subscribers have immediate access, but to make the article available on their personal and/or institutional Web sites (including so-called repositories or archives)), which is a practice allowed by many scholarly journals.
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords